SCHEMBL874671

SCHEMBL874671

CCOC(=O)C(c1ccccc1)c1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
MMP8 P22894 1/20 0.48
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
CHRM1 P11229 4/20 0.46
CHRM3 P20309 4/20 0.46
CHRM2 P08172 3/20 0.46
CHRM4 P08173 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 1/20 0.46
GAA P10253 1/20 0.44
PIN1 Q13526 1/20 0.44
HDAC4 P56524 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1154381 0.84 ALDH1A1 (0.41) TSHRMMP8LMNACYP1A2CYP2D6
SCHEMBL17583646 0.83 CYP2D6 (0.49) LMNACYP2D6CYP3A4GAA
SCHEMBL2310025 0.83 LMNA (0.62) TSHRMMP8LMNACYP1A2CYP2D6
SCHEMBL27456672 0.81 MEN1 (0.50) TSHRMMP8LMNACYP1A2CYP2D6
SCHEMBL5530167 0.80 MMP8 (0.49) TSHRMMP8CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL16795580 0.79 MMP8 (0.49) TSHRMMP8LMNACYP1A2SMN1; SMN2
SCHEMBL28165643 0.79 CES2 (0.53) TSHRMMP8CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL26606670 0.79 TSHR (0.43) TSHRMMP8LMNACYP1A2CYP2D6
SCHEMBL22917200 0.78 GAA (0.50) GAAHDAC4HDAC3HDAC7HDAC8
SCHEMBL8707058 0.78 ALDH1A1 (0.47) TSHRMMP8LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619195-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2013-07-31 EP disclosed
WO-2012039717-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-29 WO disclosed